ICMJE Form for Disclosure of Potential Conflicts of Interest
|
|
|
- Philippa Owens
- 10 years ago
- Views:
Transcription
1 Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in four parts. 1. Identifying information. Enter your full name. If you are NOT the corresponding author please check the box "no" and a space to enter the name of the corresponding author in the space that appears. Provide the requested manuscript information. Double-check the manuscript number and enter it. 2. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Then complete the appropriate boxes to indicate the type of support and whether the payment went to you, or to your institution, or both Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence,or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. Other relationships. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Casabé 1
2 Section 1. Identifying Information 1. Given Name (First Name) José Horacio 2. Surname (Last Name) Casabé 3. Effective Date (07-August-2008) 03-June Are you the corresponding author? Yes 5. Manuscript Title Endocarditis infecciosa en la miocardiopatía hipertrófica: diferentes poblaciones de una misma entidad 6. Manuscript Identifying Number (if you know it) 5476 Section 2. Did you or your institution at any time receive payment or services from a third party for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc )? Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Casabé Type Paid to You Name of Entity Comments** 1. Grant 2. Consulting fee or honorarium 3. Support for travel to meetings for the study or other purposes 4. Fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like 5. Payment for writing or reviewing the manuscript 6. Provision of writing assistance, medicines, equipment, or administrative support 2
3 Type Paid to You Name of Entity Comments** 7. Other * This means money that your institution received for your efforts on this study. ** Use this section to provide any needed explanation. Section 3. Relevant financial activities outside the submitted work. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to submission. Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) Paid to You Entity Comments 1. Board membership 2. Consultancy 3. Employment 4. Expert testimony 5. Grants/grants pending 6. Payment for lectures including service on speakers bureaus 7. Payment for manuscript preparation Casabé 3
4 Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) 8. Patents (planned, pending or issued) Paid to You Entity Comments 9. Royalties 10. Payment for development of educational presentations 11. Stock/stock options 12. Travel/accommodations/ meeting expenses unrelated to activities listed** 13. Other (err on the side of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Section 4. Other relationships Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? other relationships/conditions/circumstances that present a potential conflict of interest Yes, the following relationships/conditions/circumstances are present (explain below): At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Hide All Table Rows Checked '' SAVE Casabé 4
5 Evaluation and Feedback Please visit to provide feedback on your experience with completing this form. Casabé 5
6 Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in four parts. 1. Identifying information. Enter your full name. If you are NOT the corresponding author please check the box "no" and a space to enter the name of the corresponding author in the space that appears. Provide the requested manuscript information. Double-check the manuscript number and enter it. 2. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Then complete the appropriate boxes to indicate the type of support and whether the payment went to you, or to your institution, or both Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence,or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. Other relationships. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Fernández 1
7 Section 1. Identifying Information 1. Given Name (First Name) Adrián 2. Surname (Last Name) Fernández 3. Effective Date (07-August-2008) 03-June Are you the corresponding author? Yes Corresponding Author s Name Dr. José Horacio Casabé 5. Manuscript Title Endocarditis infecciosa en la miocardiopatía hipertrófica: diferentes poblaciones de una misma entidad 6. Manuscript Identifying Number (if you know it) 5476 Section 2. Did you or your institution at any time receive payment or services from a third party for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc )? Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Fernández Type Paid to You Name of Entity Comments** 1. Grant 2. Consulting fee or honorarium 3. Support for travel to meetings for the study or other purposes 4. Fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like 5. Payment for writing or reviewing the manuscript 6. Provision of writing assistance, medicines, equipment, or administrative support 2
8 Type Paid to You Name of Entity Comments** 7. Other * This means money that your institution received for your efforts on this study. ** Use this section to provide any needed explanation. Section 3. Relevant financial activities outside the submitted work. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to submission. Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) Paid to You Entity Comments 1. Board membership 2. Consultancy 3. Employment 4. Expert testimony 5. Grants/grants pending 6. Payment for lectures including service on speakers bureaus 7. Payment for manuscript preparation Fernández 3
9 Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) 8. Patents (planned, pending or issued) Paid to You Entity Comments 9. Royalties 10. Payment for development of educational presentations 11. Stock/stock options 12. Travel/accommodations/ meeting expenses unrelated to activities listed** 13. Other (err on the side of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Section 4. Other relationships Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? other relationships/conditions/circumstances that present a potential conflict of interest Yes, the following relationships/conditions/circumstances are present (explain below): At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Hide All Table Rows Checked '' SAVE Fernández 4
10 Evaluation and Feedback Please visit to provide feedback on your experience with completing this form. Fernández 5
11 Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in four parts. 1. Identifying information. Enter your full name. If you are NOT the corresponding author please check the box "no" and a space to enter the name of the corresponding author in the space that appears. Provide the requested manuscript information. Double-check the manuscript number and enter it. 2. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Then complete the appropriate boxes to indicate the type of support and whether the payment went to you, or to your institution, or both Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence,or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. Other relationships. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Renedo 1
12 Section 1. Identifying Information 1. Given Name (First Name) María F. 2. Surname (Last Name) Renedo 3. Effective Date (07-August-2008) 03-June Are you the corresponding author? Yes Corresponding Author s Name Dr. José Horacio Casabé 5. Manuscript Title Endocarditis infecciosa en la miocardiopatía hipertrófica: diferentes poblaciones de una misma entidad 6. Manuscript Identifying Number (if you know it) 5476 Section 2. Did you or your institution at any time receive payment or services from a third party for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc )? Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Renedo Type Paid to You Name of Entity Comments** 1. Grant 2. Consulting fee or honorarium 3. Support for travel to meetings for the study or other purposes 4. Fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like 5. Payment for writing or reviewing the manuscript 6. Provision of writing assistance, medicines, equipment, or administrative support 2
13 Type Paid to You Name of Entity Comments** 7. Other * This means money that your institution received for your efforts on this study. ** Use this section to provide any needed explanation. Section 3. Relevant financial activities outside the submitted work. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to submission. Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) Paid to You Entity Comments 1. Board membership 2. Consultancy 3. Employment 4. Expert testimony 5. Grants/grants pending 6. Payment for lectures including service on speakers bureaus 7. Payment for manuscript preparation Renedo 3
14 Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) 8. Patents (planned, pending or issued) Paid to You Entity Comments 9. Royalties 10. Payment for development of educational presentations 11. Stock/stock options 12. Travel/accommodations/ meeting expenses unrelated to activities listed** 13. Other (err on the side of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Section 4. Other relationships Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? other relationships/conditions/circumstances that present a potential conflict of interest Yes, the following relationships/conditions/circumstances are present (explain below): At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Hide All Table Rows Checked '' SAVE Renedo 4
15 Evaluation and Feedback Please visit to provide feedback on your experience with completing this form. Renedo 5
16 Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in four parts. 1. Identifying information. Enter your full name. If you are NOT the corresponding author please check the box "no" and a space to enter the name of the corresponding author in the space that appears. Provide the requested manuscript information. Double-check the manuscript number and enter it. 2. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Then complete the appropriate boxes to indicate the type of support and whether the payment went to you, or to your institution, or both Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence,or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. Other relationships. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Guevara 1
17 Section 1. Identifying Information 1. Given Name (First Name) Eduardo 2. Surname (Last Name) Guevara 3. Effective Date (07-August-2008) 03-June Are you the corresponding author? Yes Corresponding Author s Name Dr. José Horacio Casabé 5. Manuscript Title Endocarditis infecciosa en la miocardiopatía hipertrófica: diferentes poblaciones de una misma entidad 6. Manuscript Identifying Number (if you know it) 5476 Section 2. Did you or your institution at any time receive payment or services from a third party for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc )? Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Guevara Type Paid to You Name of Entity Comments** 1. Grant 2. Consulting fee or honorarium 3. Support for travel to meetings for the study or other purposes 4. Fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like 5. Payment for writing or reviewing the manuscript 6. Provision of writing assistance, medicines, equipment, or administrative support 2
18 Type Paid to You Name of Entity Comments** 7. Other * This means money that your institution received for your efforts on this study. ** Use this section to provide any needed explanation. Section 3. Relevant financial activities outside the submitted work. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to submission. Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) Paid to You Entity Comments 1. Board membership 2. Consultancy 3. Employment 4. Expert testimony 5. Grants/grants pending 6. Payment for lectures including service on speakers bureaus 7. Payment for manuscript preparation Guevara 3
19 Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) 8. Patents (planned, pending or issued) Paid to You Entity Comments 9. Royalties 10. Payment for development of educational presentations 11. Stock/stock options 12. Travel/accommodations/ meeting expenses unrelated to activities listed** 13. Other (err on the side of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Section 4. Other relationships Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? other relationships/conditions/circumstances that present a potential conflict of interest Yes, the following relationships/conditions/circumstances are present (explain below): At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Hide All Table Rows Checked '' SAVE Guevara 4
20 Evaluation and Feedback Please visit to provide feedback on your experience with completing this form. Guevara 5
21 Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in four parts. 1. Identifying information. Enter your full name. If you are NOT the corresponding author please check the box "no" and a space to enter the name of the corresponding author in the space that appears. Provide the requested manuscript information. Double-check the manuscript number and enter it. 2. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Then complete the appropriate boxes to indicate the type of support and whether the payment went to you, or to your institution, or both Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence,or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. Other relationships. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Favaloro 1
22 Section 1. Identifying Information 1. Given Name (First Name) Liliana E. 2. Surname (Last Name) Favaloro 3. Effective Date (07-August-2008) 03-June Are you the corresponding author? Yes Corresponding Author s Name Dr. José Horacio Casabé 5. Manuscript Title Endocarditis infecciosa en la miocardiopatía hipertrófica: diferentes poblaciones de una misma entidad 6. Manuscript Identifying Number (if you know it) 5476 Section 2. Did you or your institution at any time receive payment or services from a third party for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc )? Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Favaloro Type Paid to You Name of Entity Comments** 1. Grant 2. Consulting fee or honorarium 3. Support for travel to meetings for the study or other purposes 4. Fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like 5. Payment for writing or reviewing the manuscript 6. Provision of writing assistance, medicines, equipment, or administrative support 2
23 Type Paid to You Name of Entity Comments** 7. Other * This means money that your institution received for your efforts on this study. ** Use this section to provide any needed explanation. Section 3. Relevant financial activities outside the submitted work. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to submission. Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) Paid to You Entity Comments 1. Board membership 2. Consultancy 3. Employment 4. Expert testimony 5. Grants/grants pending 6. Payment for lectures including service on speakers bureaus 7. Payment for manuscript preparation Favaloro 3
24 Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) 8. Patents (planned, pending or issued) Paid to You Entity Comments 9. Royalties 10. Payment for development of educational presentations 11. Stock/stock options 12. Travel/accommodations/ meeting expenses unrelated to activities listed** 13. Other (err on the side of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Section 4. Other relationships Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? other relationships/conditions/circumstances that present a potential conflict of interest Yes, the following relationships/conditions/circumstances are present (explain below): At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Hide All Table Rows Checked '' SAVE Favaloro 4
25 Evaluation and Feedback Please visit to provide feedback on your experience with completing this form. Favaloro 5
26 Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in four parts. 1. Identifying information. Enter your full name. If you are NOT the corresponding author please check the box "no" and a space to enter the name of the corresponding author in the space that appears. Provide the requested manuscript information. Double-check the manuscript number and enter it. 2. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Then complete the appropriate boxes to indicate the type of support and whether the payment went to you, or to your institution, or both Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence,or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. Other relationships. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Favaloro 1
27 Section 1. Identifying Information 1. Given Name (First Name) Roberto R. 2. Surname (Last Name) Favaloro 3. Effective Date (07-August-2008) 03-June Are you the corresponding author? Yes 5. Manuscript Title Endocarditis infecciosa en la miocardiopatía hipertrófica: diferentes poblaciones de una misma entidad 6. Manuscript Identifying Number (if you know it) 5476 Section 2. Did you or your institution at any time receive payment or services from a third party for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc )? Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Favaloro Type Paid to You Name of Entity Comments** 1. Grant 2. Consulting fee or honorarium 3. Support for travel to meetings for the study or other purposes 4. Fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like 5. Payment for writing or reviewing the manuscript 6. Provision of writing assistance, medicines, equipment, or administrative support 2
28 Type Paid to You Name of Entity Comments** 7. Other * This means money that your institution received for your efforts on this study. ** Use this section to provide any needed explanation. Section 3. Relevant financial activities outside the submitted work. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to submission. Complete each row by checking or providing the requested information. If you have more than one relationship click the Add button to add a row. Excess rows can be removed by clicking the X button. Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) Paid to You Entity Comments 1. Board membership 2. Consultancy 3. Employment 4. Expert testimony 5. Grants/grants pending 6. Payment for lectures including service on speakers bureaus 7. Payment for manuscript preparation Favaloro 3
29 Relevant financial activities outside the submitted work Type of Relationship (in alphabetical order) 8. Patents (planned, pending or issued) Paid to You Entity Comments 9. Royalties 10. Payment for development of educational presentations 11. Stock/stock options 12. Travel/accommodations/ meeting expenses unrelated to activities listed** 13. Other (err on the side of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Section 4. Other relationships Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? other relationships/conditions/circumstances that present a potential conflict of interest Yes, the following relationships/conditions/circumstances are present (explain below): At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Hide All Table Rows Checked '' SAVE Favaloro 4
30 Evaluation and Feedback Please visit to provide feedback on your experience with completing this form. Favaloro 5
ICMJE Form for Disclosure of Potential Conflicts of Interest
Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed
ICMJE Form for Disclosure of Potential Conflicts of Interest
Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed
ICMJE Form for Disclosure of Potential Conflicts of Interest
Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed
Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction
Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy Introduction The faculty 1 and medical students of the Joan C. Edwards School of Medicine (SOM) have responsibilities
Financial Conflict Of Interest (FCOI) Policy for Public Health Service (PHS) Funding
Financial Conflict Of Interest (FCOI) Policy for Public Health Service (PHS) Funding (in accordance with 42 CFR Part 50- Subpart F, and 45 CFR Part 9.) I. PURPOSE & SCOPE This Policy implements the 2011
EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS. Table of Contents
EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL RELATIONSHIPS Table of Contents EMORY UNIVERSITY SCHOOL OF MEDICINE POLICY ON INDUSTRY AND OTHER EXTERNAL PROFESSIONAL
ORE 101 Appendix B: UNIVERSITY OF WATERLOO. Conflict of Interest Disclosure Form (pursuant to Policy 69) and
ORE 101 Appendix B: UNIVERSITY OF WATERLOO Conflict of Interest Disclosure Form (pursuant to Policy 69) and Researcher Declaration of Conflict of Interest Name: Title and Rank: Study Title: Department:
Required Forms Checklist:
Proposal Submission Please use this cover letter for all submissions. Title of Workshop: Submitted by: (Main Contact Name) Organization: Mailing Address : Email: Phone: Type Abstract Here: Objective and
International Transplant Nurses Society Speaker / Planner Bio Form
Ohio Nurses Association Biographical Data Form (2009 Criteria) Instructions: If you are a planner for this activity, complete Sections 1, 2, 4, 5 & 7. If you are a speaker/ content expert for this activity,
AMERICAN PSYCHIATRIC NURSES ASSOCIATION. Collaborating in an Evolving Health Care System: Opportunities to Advance Psychiatric-Mental Health Nursing
AMERICAN PSYCHIATRIC NURSES ASSOCIATION 29th Annual Conference Collaborating in an Evolving Health Care System: Opportunities to Advance Psychiatric-Mental Health Nursing Disney's Coronado Springs Resort
INSTRUCTIONS TO JOINT PROVIDERS OF CME ACTIVITIES
INSTRUCTIONS TO JOINT PROVIDERS OF CME ACTIVITIES TABLE OF CONTENTS 1. OVERVIEW AND TIMELINE... 2 2. Online Application Process... 4 3. POLICIES... 4 Use of Accreditation Statement... 4 ATS CME Mission...
How To Disclose Your Financial Interests In A University Business
THE UNIVERSITY OF TENNESSEE Faculty and Staff OUTSIDE INTEREST DISCLOSURE FORM NAME PERSONNEL NO. TITLE CAMPUS/INSTITUTE DEPARTMENT COST CENTER Instructions: This form is for the University of Tennessee
University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents
University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial
Required Forms Checklist:
Proposal Submission Please use this cover letter for all submissions. Title of Workshop: Submitted by: (Main Contact Name) Organization: Mailing Address : Email: Phone: Type Abstract Here: Objective and
University of Cincinnati College of Medicine
University of Cincinnati College of Medicine Policy Policy and Guidelines for Industry Relationships Policy and Guidelines for Industry Relationships FAQ Date Updated Page 5/14/2008 2 -- 8 NB: The Institute
The Johns Hopkins Technology Ventures Inventor Portal How to Submit an Invention Disclosure Table of Contents
The Johns Hopkins Technology Ventures Inventor Portal How to Submit an Invention Disclosure Table of Contents 1. Requesting an Account Page 2. 2. Logging In to the Inventor Portal Page 4. 3. Administrative
CORPORATE GOVERNANCE GUIDELINES OF TRIBUNE PUBLISHING COMPANY. Adopted as of August 4, 2014
CORPORATE GOVERNANCE GUIDELINES OF TRIBUNE PUBLISHING COMPANY Adopted as of August 4, 2014 The Board of Directors (the Board ) of Tribune Publishing Company (the Company ) is elected by the stockholders
Conflict of Interest Electronic Document Quick Reference Guide
Conflict of Interest Electronic Document Quick Reference Guide The following quick reference provides guidance for using the Electronic Document Signature (EDS) system for the Conflict of Interest (COI)
Q&A Intellectual Property Policy
Q&A Intellectual Property Policy Table of Contents Q: Why have an Intellectual Property Policy?... 3 Q: Does the IP Policy apply to me?... 3 Q: I am primarily affiliated with another institution and am
MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations
MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD [email protected] DISCLAIMER: For informational
CIHR Reviewers Guide for New Investigator Salary Awards
CIHR Reviewers Guide for New Investigator Salary Awards October 2014 Table of Contents INTRODUCTION... 3 PEER REVIEW AT CIHR... 3 SUMMARY OF THE PEER REVIEW PROCESS... 3 STAGE 1: INDIVIDUAL REVIEW... 4
Conflict of Interest Policy
Conflict of Interest Policy I. Purpose This policy provides guidance regarding conflicts of interest and is intended to supplement, but not replace, state and federal laws governing conflicts of interest
I, Salvador Antonetti Zequeira, Secretary of the Board of Trustees of the. University of Puerto Rico, DO HEREBY CERTIFY THAT:
BOARD OF TRUSTEES UNIVERSITY OF PUERTO RICO CERTIFICATION NUMBER 63 2007-2008 I, Salvador Antonetti Zequeira, Secretary of the Board of Trustees of the University of Puerto Rico, DO HEREBY CERTIFY THAT:
2. All Island Health CME/PD activities must be free of any real or perceived commercial bias.
[Type Island Health Guidelines for Commercial Support of Continuing Medical Education/Continuing Professional Development Activities The following document outlines the guiding principles pertaining to
CMSS Physician Payment Sunshine Act FAQs
CMSS Physician Payment Sunshine Act FAQs These FAQs are intended as a resource for CMSS member organizations to create their own guidance document. The answers are based on the guidance that is publicly
Financial Procedure Note FPN 13. Financial Conflict of Interest Policy
Financial Procedure Note FPN 13 Financial Conflict of Interest Policy September 2013 Financial Procedure Notes supplement Financial Regulations, providing detailed guidance on various topics. Failure to
Sensing the Body Electric: Biomarkers of Epileptic Brain
Current Literature In Clinical Science Sensing the Body Electric: Biomarkers of Epileptic Brain Removing Interictal Fast Ripples on Electrocorticography Linked With Seizure Freedom in Children. Wu JY,
Printed copies are for reference only. Please refer to the electronic copy for the latest version.
Title: FINANCIAL CONFLICT OF INTEREST POLICY FOR PUBLIC HEALTH SERVICE-SPONSORED RESEARCH STUDIES Document Owner: Joyce Romans Approver(s): Joyce Romans, Mary Ann Kowalczyk Effective Date: 04/14/2014 Printed
PhRMA Code on Interactions with Healthcare Professionals
PhRMA Code on Interactions with Healthcare Professionals Preamble The Pharmaceutical Research and Manufacturers of America (PhRA4.A) represents research-basedpharmaceutical and biotechnology companies.
ADMINISTRATIVE MEMORANDUM. Significant Financial Disclosure Policy for Sponsored Research Investigators
ADMINISTRATIVE MEMORANDUM To: From: Subject: Vice Presidents, Deans, Directors, Department Chairs, and Other Administrative Officials Salme Harju Steinberg, President Significant Financial Disclosure Policy
Winthrop University Hospital Research Financial Interests Disclosure Policy
This policy sets forth Winthrop-University Hospital s (WUH) requirements and guidelines for disclosing applicable Research Financial Interests. It includes: I. Definitions of Key Terms II. Policy and Procedures
MODEL INTELLECTUAL PROPERTY POLICY FOR UNIVERSITIES AND RESEARCH INSTITUTIONS
MODEL INTELLECTUAL PROPERTY POLICY FOR UNIVERSITIES AND RESEARCH INSTITUTIONS Version One Prepared by the Division for Certain Countries in Europe and Asia 1 1. Introduction 1 The Institute recognizes
Code on Interactions with Healthcare. Professionals
Code on Interactions with Healthcare Professionals Table of Contents Preamble 1 Basis of Interactions 2 Informational Presentations by Pharmaceutical Company Representatives and Accompanying Meals 3 Prohibition
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance Objectives NCI s Clinical Trials Reporting Program (CTRP) Overview CTRP What is it? CTRP is an NCI mandated
Global Policy on Interactions with Healthcare Professionals
Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Pfizer is committed to collaborating with physicians and other healthcare professionals,
Return of Organization Exempt From Income Tax
Form 990 Return of Organization Exempt From Income Tax OMB No. 1545-0047 Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except black lung 2010 benefit trust or private foundation)
City or Town, State or Country and ZIP+ 4 5. Home Email Address. 6. Work Address (Number and Street) Room/Suite 7. Work Telephone Number
Form CHAR012 Professional Solicitor Registration Statement The Capitol Albany, NY 12224 http://www.charitiesnys.com Open to Public Inspection Article 7-A of the Executive Law (excluding page 3) Part A
University of Miami Miller School of Medicine
University of Miami Miller School of Medicine Policy UMMG [University of Miami Medical Group] Policy: Pharmaceutical/Device Representative Interaction Division of Continuing Medical Education Website Date
Craig Hallum Conference Investor Presentation
Craig Hallum Conference Investor Presentation Improving cancer outcomes with groundbreaking precision in molecular testing Paul Kinnon President and CEO Sept 2015 1 Forward-Looking Statements Certain statements
Amgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,
Form 990 Return of Organization Exempt From Income Tax
OMB No. 1545-0047 Form 990 Return of Organization Exempt From Income Tax Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except black lung 2011 benefit trust or private foundation)
Conflicts of Interest and Conflicts of Commitment Compliance Training
Conflicts of Interest and Conflicts of Commitment Compliance Training 1 Objectives By the end of this lesson, you should be able to: Recognize: The potential for conflicts and how to avoid them in your
Private Health Insurance Intermediaries. Document 2: Self-Audit Questionnaire. Version 2
Private Health Insurance Intermediaries Document 2: Self-Audit Questionnaire For All Members of PHIIA JUNE 2015 Version 2 9 For All Members of PHIIA Code Compliance Committee Private Health Insurance Intermediaries
A Guide to the ABTA s 2013 Medical Student Summer Fellowship Application
A Guide to the ABTA s 2013 Medical Student Summer Fellowship Application Please be aware the submission process has changed. All applications for the 2013 American Brain Tumor Association Medical Student
Engaged Management ReView Reviewer Guidelines V.1.0. Friday, March 11, 2015
Engaged Management ReView Reviewer Guidelines V.1.0 Friday, March 11, 2015 Table of Contents Engaged Management ReView (EMR) Reviewer Guidelines... 3 SECTION 1: Reviewer Receiving Invitation to Review
Emory Healthcare Policy on Relationships with Vendors, Industry and Other External Professional Relationships
Final Version 1,12,2010 Emory Healthcare Policy on Relationships with Vendors, Industry and Other External Professional Relationships 1. Scope 2. Overview 3. Applicability 4. General Policy 5. Gifts/Donations
NEW YORK STATE EXTERNAL APPEAL
NEW YORK STATE EXTERNAL APPEAL You have the right to appeal to the Department of Financial Services (DFS) when your insurer or HMO denies health care services as not medically necessary, experimental/investigational
Charitable Solicitations Questionnaire
BBB Serving Western Michigan Educational Foundation 2627 E Beltline Ave SE, Ste 320 Grand Rapids, MI 49546 616-774-8236 www.westernmichigan.bbb.org Charitable Solicitations Questionnaire Contact information
HACKENSACK UNIVERSITY MEDICAL CENTER Research Department Policies and Procedures Manual
Policy Name: Research Grant Submissions Process HACKENSACK UNIVERSITY MEDICAL CENTER Research Department Policies and Procedures Manual Policy #: SPO_003 Effective Date: 01/01/2009 Page 1 of 9 GENERAL
Conduct of clinical Trials Communication of
PrinciPles on Conduct of clinical Trials Communication of clinical Trial results Table of Contents Preamble...1 Commitment to Protecting Research Participants...5 Conduct of Clinical Trials...7 Ensuring
GOVERNMENT OF THE DISTRICT OF COLUMBIA Department of Health
GOVERNMENT OF THE DISTRICT OF COLUMBIA Department of Health Prescription Drug Marketing Costs A Guide for Pharmaceutical Manufacturers and Labelers Published by the District of Columbia Department of Health
MEG Extension Application
MEG Extension Application Procedure for Continuation and/or Expansion of an Existing Grant-supported Initiative Where Additional Funding is Requested This procedure is modeled after the NIH procedure for
Financial Planner Remuneration
Financial Planner Remuneration Discussion Paper 28 February 2014 Background In 2011 the FPI formed a Remunerations Working Group ( WG ). The objective of the WG was to investigate, analyse and formulate
EMPLOYMENT APPLICATION We are an Equal Opportunity Employer
EMPLOYMENT APPLICATION We are an Equal Opportunity Employer Please print in ink. You must complete entire application. Date: Applicant Information Name (first, middle, last) (street, city, state, zip code)
Tips for Web Filers. Tips for Web Filers. New Company Registration Page
Please read all information and instructions prior to entering the data. The instructions provide important details about completing the form and will help make your web experience a positive one. 1. How
STANDARDS PROGRAM For Canada s Charities & Nonprofits
STANDARDS PROGRAM For Canada s Charities & Nonprofits Revised October 2014 Lions Foundation of Canada Dog Guides SickKids Foundation World Vision Enhancing governance and effectiveness Founding and presenting
Changing Paradigms for evaluating costs and benefits of drug treatments. Deven Chauhan Health Economist Office of Health Economics London, UK
Changing Paradigms for evaluating costs and benefits of drug treatments Deven Chauhan Health Economist Office of Health Economics London, UK What do we mean by changing paradigms? Elevating pharmaceutical
GRI Content Index Service
GRI Content Index Service Methodology GRI (year) Introduction The GRI G4 Sustainability Reporting Guidelines have increased user-friendliness and accessibility. The emphasis on what is material encourages
Principles Governing Academy Relationships with External Sources of Support
Principles Governing Academy Relationships with External Sources of Support Adopted by American Academy of Neurology American Academy of Neurology Institute American Brain Foundation June 2013 I. Preamble
Gilead Transparency Reporting Methodological Note
Gilead Transparency Reporting Methodological Note Contents 1 Introduction... 2 2 Definition of Transfers of Value... 2 3 Definition and management of Cross-Border Spend... 3 4 Which Recipients of Transfers
Health Professional Zone: Member validation and virtual quote. User manual and frequently asked questions
Health Professional Zone: Member validation and virtual quote User manual and frequently asked questions About this guide We ve improved some of the online functionalities member validation and simulate
